CI
AGIO icon

Capital International’s Agios Pharmaceuticals AGIO Stock Holding History

Capital International’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-62,358
Closed -$2.18M – 160
2020
Q3 		$2.18M Buy
62,358
+8,810
+16% +$386K 0.15% 114
2020
Q2 		$2.86M Hold
53,548
– – 0.27% 82
2020
Q1 		$1.9M Sell
53,548
-5,860
-10% -$271K 0.21% 105
2019
Q4 		$2.84M Buy
59,408
+21,322
+56% +$806K 0.3% 85
2019
Q3 		$1.23M Buy
38,086
+24,621
+183% +$1.02M 0.19% 102
2019
Q2 		$672K Buy
13,465
+847
+7% +$45.3K 0.16% 108
2019
Q1 		$851K Hold
12,618
– – 0.2% 104
2018
Q4 		$582K Sell
12,618
-326
-3% -$20.1K 0.16% 105
2018
Q3 		$998K Sell
12,944
-12,240
-49% -$985K 0.31% 88
2018
Q2 		$2.12M Sell
25,184
-3,356
-12% -$293K 0.37% 79
2018
Q1 		$2.33M Sell
28,540
-3,650
-11% -$282K 0.42% 73
2017
Q4 		$1.84M Sell
32,190
-209,147
-87% -$13.2M 0.35% 86
2017
Q3 		$16.1M Sell
241,337
-99,000
-29% -$5.95M 1.06% 42
2017
Q2 		$17.5M Sell
340,337
-6,600
-2% -$337K 1.16% 36
2017
Q1 		$20.3M Buy
346,937
+2,800
+0.8% +$134K 1.32% 27
2016
Q4 		$14.4M Buy
344,137
+81,337
+31% +$4.27M 1% 38
2016
Q3 		$13.9M Buy
262,800
+2,200
+0.8% +$95.8K 0.98% 39
2016
Q2 		$10.9M Buy
260,600
+91,900
+54% +$4.54M 0.79% 51
2016
Q1 		$6.85M Buy
168,700
+2,500
+2% +$107K 0.44% 69
2015
Q4 		$10.8M Buy
166,200
+19,000
+13% +$1.25M 0.68% 49
2015
Q3 		$10.4M Buy
147,200
+8,700
+6% +$850K 0.69% 52
2015
Q2 		$15.4M Sell
138,500
-18,400
-12% -$1.98M 0.91% 40
2015
Q1 		$14.8M Buy
156,900
+18,700
+14% +$2.1M 0.9% 42
2014
Q4 		$15.5M Buy
+138,200
New +$12.3M 0.94% 40

Other funds holding AGIO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Capital International's AGIO Position: Q4 2020 in Review

Capital International sold out of Agios Pharmaceuticals (AGIO) in Q4 2020, closing a stake of 62,358 shares — an estimated $2.18M sold.

Capital International first reported a position in AGIO in Q4 2014 and held it in 24 quarters. The position peaked at $20.3M in Q1 2017. 201 funds tracked by Wall St. Rank hold AGIO as of Q4 2020.

  • Capital International reported no remaining Agios Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Capital International sold 62,358 Agios Pharmaceuticals shares in Q4 2020, an estimated $2.18M.
  • Capital International first reported a position in Agios Pharmaceuticals in Q4 2014 and held it in 24 quarters.
  • Capital International's Agios Pharmaceuticals position peaked at $20.3M in Q1 2017.
  • 201 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2020.

Based on Capital International's 13F filing for Q4 2020, filed 16 Feb 2021.